{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:53:17Z","timestamp":1782492797278,"version":"3.54.5"},"reference-count":22,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study explores perceptions of inhaled medications among patients with asthma at an outpatient tertiary care setting in Northern Sri Lanka.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A descriptive qualitative research design was used to gather data through focus group discussions (FGDs) that were transcribed, translated, manually coded and thematically analysed using Braun and Clarke\u2019s six-step approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The study was conducted at an outpatient medical clinic at a tertiary care centre in Northern Sri Lanka.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Six FGDs were carried out among adult patients with asthma who had been on inhaled medications for at least 3\u2009months. Participants were selected by maximum variation sampling, with each FGD consisting of 6\u201310 participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>51 participants between the ages of 20 and 71 years were recruited; 36 (70.6%) were female, and about a fourth had primary education or less. Seven subthemes were drawn out and organised into three overarching themes: (1) inhaler hesitancy; (2) fear-driven adherence and (3) conviction at last. Most participants were initially reluctant to use inhalers, primarily due to concerns about dependency and side effects, often influenced by opinions of family members. They delayed use until they experienced severe symptoms, with some describing nebulisation, hospitalisation and fear of death as turning points. Symptom alleviation and improved quality of life led to better adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Delays in inhaler use could lead to poor asthma control and outcomes. As many patients reported using their inhalers more consistently after an exacerbation or hospitalisation, asthma education programmes, involving both patients and family members, could address context-specific beliefs and misconceptions to promote early and sustained adherence to inhaled medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114082","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:20:48Z","timestamp":1774534848000},"page":"e114082","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Patient perceptions of inhaled asthma medications: a qualitative study in Northern Sri Lanka"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-8230","authenticated-orcid":false,"given":"Yalini","family":"Guruparan","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Jaffna, Jaffna, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiyahiny S","family":"Navaratinaraja","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Jaffna, Jaffna, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowry","family":"Selvaratnam","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0184-104X","authenticated-orcid":false,"given":"Shalini Sri","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Colombo, Colombo, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"2026062609364342000_16.3.e114082.1","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention 2024. Available: https:\/\/ginasthma.org\/wp-content\/uploads\/2024\/05\/GINA-2024-Strategy-Report-24_05_22_WMS.pdf [Accessed 10 Oct 2025]."},{"key":"2026062609364342000_16.3.e114082.2","first-page":"1","article-title":"The Global Asthma Report 2022","volume":"26","year":"2022","journal-title":"Int j Tuberc Lung Dis"},{"key":"2026062609364342000_16.3.e114082.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-14793-3","article-title":"Prevalence of asthma and its symptoms in Sri Lankan adults","volume":"22","author":"Gunasekera","year":"2022","journal-title":"BMC Public Health"},{"key":"2026062609364342000_16.3.e114082.4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00001615"},{"key":"2026062609364342000_16.3.e114082.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.105859"},{"key":"2026062609364342000_16.3.e114082.6","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0176-2021","article-title":"Current unmet needs and potential solutions to uncontrolled asthma","volume":"31","author":"Busse","year":"2022","journal-title":"Eur Respir Rev"},{"key":"2026062609364342000_16.3.e114082.7","doi-asserted-by":"crossref","DOI":"10.1186\/s40359-023-01097-3","article-title":"Effect of illness perceptions on asthma control and quality of life amongst adult outpatients with asthma in China","volume":"11","author":"Cai","year":"2023","journal-title":"BMC Psychol"},{"key":"2026062609364342000_16.3.e114082.8","doi-asserted-by":"crossref","first-page":"01346","DOI":"10.1183\/13993003.01346-2017","article-title":"Understanding patients\u2019 perceptions of asthma control: A qualitative study","volume":"51","author":"Bidad","year":"2018","journal-title":"Eur Respir J"},{"key":"2026062609364342000_16.3.e114082.9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/JAA.S407552","article-title":"Medication Adherence in People with Asthma: A Qualitative Systematic Review of Patient and Health Professional Perspectives","volume":"16","author":"Zhang","year":"2023","journal-title":"J Asthma Allergy"},{"key":"2026062609364342000_16.3.e114082.10","doi-asserted-by":"crossref","first-page":"00528","DOI":"10.1183\/23120541.00528-2020","article-title":"Patients\u2019 experiences of asthma exacerbation and management: a qualitative study of severe asthma","volume":"7","author":"Song","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026062609364342000_16.3.e114082.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-024-00390-x","article-title":"Beliefs surrounding the use of inhaled asthma medication in The Gambia: a qualitative study of asthma patients and healthcare workers","volume":"34","author":"Jayasooriya","year":"2024","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026062609364342000_16.3.e114082.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037491","article-title":"Patient preferences for asthma management: a qualitative study","volume":"10","author":"Baggott","year":"2020","journal-title":"BMJ Open"},{"key":"2026062609364342000_16.3.e114082.13","unstructured":"Rajapaksa L , Silva P , Abeykoon A , et al . Sri Lanka health system review. World Health Organization Regional Office for South-East Asia; 2021. Available: https:\/\/wkc.who.int\/resources\/publications\/i\/item\/sri-lanka-health-system-review"},{"key":"2026062609364342000_16.3.e114082.14","unstructured":"Govindaraj R , Navaratne K , Cavagnero E , et al . Health care in Sri Lanka: what can the private health sector offer? health, nutrition and population (HNP) discussion paper series 89554, the world bank 2014. Available: https:\/\/documents1.worldbank.org\/curated\/en\/423511468307190661\/pdf\/899540WP0Box380th0Care0in0Sri0Lanka.pdf [Accessed 10 Oct 2025]."},{"key":"2026062609364342000_16.3.e114082.15","unstructured":"Sri Lanka national health accounts 2017 and 2018. Ministry of Health, Sri Lanka; 2022. Available: https:\/\/www.health.gov.lk\/wp-content\/uploads\/2022\/08\/National-Health-Accounts-Sri-Lanka-Final-version-23.06.2022.pdf [Accessed 10 Oct 2025]."},{"key":"2026062609364342000_16.3.e114082.16","doi-asserted-by":"crossref","first-page":"e1423","DOI":"10.1016\/S2214-109X(22)00330-8","article-title":"The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review","volume":"10","author":"Stolbrink","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2026062609364342000_16.3.e114082.17","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"2026062609364342000_16.3.e114082.18","doi-asserted-by":"crossref","first-page":"114523","DOI":"10.1016\/j.socscimed.2021.114523","article-title":"Sample sizes for saturation in qualitative research: A systematic review of empirical tests","volume":"292","author":"Hennink","year":"2022","journal-title":"Social Science & Medicine"},{"key":"2026062609364342000_16.3.e114082.19","doi-asserted-by":"publisher","DOI":"10.1177\/1049732318821692"},{"key":"2026062609364342000_16.3.e114082.20","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2026062609364342000_16.3.e114082.21","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.1459"},{"key":"2026062609364342000_16.3.e114082.22","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s12325-017-0557-0","article-title":"Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups","volume":"34","author":"Svedsater","year":"2017","journal-title":"Adv Ther"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:41:50Z","timestamp":1782492110000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,26]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-114082"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114082","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}